MedTrace Logo

Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer

NCT03958019 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-04-13

No results posted yet for this study

Summary

The RESTORE II randomized controlled trial will examine the efficacy of a 12 week multidisciplinary rehabilitation program consisting of supervised and home-based exercise,1:1 dietetic counselling, and group education sessions for survivors of upper gastrointestinal cancer, namely cancers of the oesophagus, stomach, pancreas, and liver.

Conditions

Interventions

OTHER

RESTORE II Program

Detailed in arm description

Sponsors & Collaborators

  • Health Research Board, Ireland

    collaborator OTHER

  • St. James's Hospital, Ireland

    collaborator OTHER

  • St Vincent's University Hospital, Ireland

    collaborator OTHER

  • Tallaght University Hospital

    collaborator OTHER

  • University of Dublin, Trinity College

    lead OTHER

Principal Investigators

  • Juliette Hussey, PhD · Professor in Physiotherapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-25
Primary Completion
2024-06-01
Completion
2024-12-01

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03958019 on ClinicalTrials.gov